Video Experimental Relacionado
Updated: May 8, 2026
08:53
In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
Inmunoterapia basada en anticuerpos para el cáncer
Louis M Weiner1, Joseph C Murray, Casey W Shuptrine
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3800 Reservoir Road NW, Washington, DC 20007, USA. weinerl@georgetown.edu
Cell
|March 20, 2012
Resumen
Los anticuerpos monoclonales están revolucionando la terapia contra el cáncer al atacar las células tumorales o las células inmunes para aumentar las respuestas antitumorales. Estas innovadoras estrategias de anticuerpos están dando forma al futuro del tratamiento del cáncer.
Área de la Ciencia:
- Inmunología Inmunología.
- Oncología Oncología.
- Biotecnología La biotecnología es la biotecnología.
Sus antecedentes:
- Los anticuerpos monoclonales (mAbs) son terapias efectivas contra el cáncer al dirigirse a antígenos específicos del tumor.
- Las estrategias emergentes aprovechan mAbs para modular el sistema inmunológico para una mayor actividad antitumoral.
- Estos enfoques se centran en las células inmunes en lugar de los antígenos tumorales.
Objetivo del estudio:
- Revisar estrategias innovadoras basadas en anticuerpos en la terapia del cáncer.
- Discutir el impacto de dirigir las células inmunes para el tratamiento del cáncer.
- Proponer direcciones futuras para la inmunoterapia contra el cáncer basada en anticuerpos.
Principales métodos:
- Revisión de la literatura de los avances recientes en la terapia del cáncer basada en anticuerpos.
- Análisis de estrategias dirigidas a las células inmunes para mejorar las respuestas antitumorales.
- Discusión de las implicaciones para el futuro desarrollo terapéutico.
Principales resultados:
- Las estrategias basadas en anticuerpos dirigidas a las células inmunes son prometedoras independientemente de la expresión del antígeno tumoral.
- Estos nuevos enfoques mejoran la respuesta inmune natural del cuerpo contra el cáncer.
- Se han logrado avances significativos en el desarrollo de terapias de anticuerpos inmunocéntricos.
Conclusiones:
- Dirigirse a las células inmunes representa un cambio de paradigma en la terapia del cáncer basada en anticuerpos.
- Es probable que los futuros tratamientos contra el cáncer incorporen estas innovadoras estrategias de anticuerpos inmunomoduladores.
- La ingeniería de anticuerpos continúa impulsando los avances en oncología.
Videos de Conceptos Relacionados
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...